breakman1010
Posted - 3 days ago
$JAGX $apre
Deepsyd
Posted - 1 week ago
$APRE Just 30 days left till CVR expiry if you feel like selling anything Gilad….
Stock_Titan
Posted - 2 weeks ago
$APRE Aprea Therapeutics Announces Presentations on its Next Generation WEE1 Inhibitor, APR-1051, and A Novel Macrocyclic ATR Inhibitor, ATRN-119, at AACR Annual Meeting 2024
https://www.stocktitan.net/news/APRE/aprea-therapeutics-announces-presentations-on-its-next-generation-88p8ok3dfvz1.html
STONKSROCKET
Posted - 2 weeks ago
$APRE do we have any possible catalysts coming up? Any information would be appreciated.
OpenOutcrier
Posted - 3 weeks ago
$APRE (-6.5% pre) Aprea Therapeutics (APRE) Announces 4.39M Share Offering by Selling Stockholders - SI https://ooc.bz/l/29431
BornKing
Posted - 3 weeks ago
$APRE same story, they hid from shareholders under the umbrella on a terrible acquisition,R/S/offering. They fuqn broke
BornKing
Posted - 3 weeks ago
$APRE told yall they hustled us pre reverse split & shitty offering. Put hands & feet on management on sight🧐☕️
DonCorleone77
Posted - 3 weeks ago
$APRE Aprea Therapeutics files to sell 4.39M shares of common stock for holders
BornKing
Posted - 3 weeks ago
$APRE still bih
Papilove
Posted - 3 weeks ago
$APRE @CharlesV @DTPantera King Charles I hope all is well with you and your family and you had a blessed resurrection Sunday yesterday. I need your help please with some information. In one or more of your previous posts, you mentioned that there was an FDA meeting with APRE executives around Q1 of 2022. You said some guy who runs a fund got inside information about this meeting and started shorting the stock. Also he was helped by Stock Authority. I am suing both of these people and anyone else involved on charges of conspiracy to commit securities fraud. This can bleed over to a lawsuit against APRE for non-disclosure of material information that resulted in huge investment losses. I need the names and all information you can help with. I found a second law firm to handle this case, whereas I have Cohen Milstein for the class-action involving the CVR. Thanks very much my friend.
BornKing
Posted - 03/28/24
$APRE $46 a share or this 💩 is forever trash scam
Fullratio
Posted - 03/27/24
$APRE current ratio has decreased by 45% YoY and by 16% from the previous quarter: https://fullratio.com/stocks/nasdaq-apre/aprea-therapeutics
DonCorleone77
Posted - 03/26/24
$APRE Aprea Therapeutics sees cash runway into 3Q25 As of December 31, 2023, the Company reported cash and cash equivalents of $21.6 million compared to $28.8 million as of December 31, 2022. The Company believes its cash and cash equivalents as of December 31, 2023, combined with the upfront gross proceeds of approximately $16.0 million received from the Company's private placement of common stock and warrants in March 2024, before deducting placement agent fees and offering costs of approximately $1.4 million, will be sufficient to meet its currently projected operating expenses and capital expenditure requirements into the third quarter of 2025.
DonCorleone77
Posted - 03/26/24
$APRE 2 of 2 - Aprea Therapeutics reports Q4 EPS (92c), consensus (77c) ....Based on the unique characteristics of APR-1051 we believe it will be best in class. The closing of our recent private placement financing provides us with the capital to fund both of these lead programs through meaningful clinical milestones. I would like to thank our dedicated team, our academic collaborators, as well as existing and new investors who have supported our recent advancements. Our mission is to be a global leader in synthetic lethality and we see a great opportunity to help cancer patients in need and create value for our shareholders."
DonCorleone77
Posted - 03/26/24
$APRE 1 of 2 - Aprea Therapeutics reports Q4 EPS (92c), consensus (77c) Reports Q4 revenue $14,075. "Aprea had a very productive 2023 with significant progress across our diversified pipeline of synthetic lethality-based cancer therapeutics. We are pleased to continue this positive momentum in 2024 and focus on the execution on our programs towards successfully delivering potentially safer and more effective therapies for cancer patients," said Oren Gilad, Ph.D., President and Chief Executive Officer of Aprea. "We continue to enroll and treat patients in the ongoing Phase 1/2a study of our novel macrocyclic ATR inhibitor, ATRN-119. ATRN-119 appears to be well tolerated with a manageable toxicity profile. Dose escalation will proceed throughout 2024 with potential for human efficacy data in the second half of the year. We are preparing to enter the clinic with our next generation inhibitor of WEE1 kinase, APR-1051, having received clearance from the FDA on our IND....
Stock_Titan
Posted - 03/26/24
$APRE Aprea Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Business Update
https://www.stocktitan.net/news/APRE/aprea-therapeutics-reports-fourth-quarter-and-full-year-2023-qp8d0w56vbqv.html
DTPantera
Posted - 1 month ago
$APRE an epic POS
stockobserver
Posted - 1 month ago
$APRE Still cheap
dcast
Posted - 1 month ago
$APRE marching back up. ready for the 7's
stockobserver
Posted - 1 month ago
$APRE Told you last week
So undervalued.
Now it’s hard to get shares.
RollingDollar
Posted - 1 month ago
$APRE
RollingDollar
Posted - 1 month ago
$APRE
RollingDollar
Posted - 1 month ago
$APRE
_StockTrader
Posted - 1 month ago
Real-Time Stock Data $APRE
Price: 6.55
Volume: 21691
Market Cap: 21897260
PE Ratio: -2.616116
Powered by: AITX
stockobserver
Posted - 1 month ago
$APRE Screaming buy!
stockobserver
Posted - 1 month ago
$APRE Like a thief in the night
Adding all week
Look at the The terms of the finance and we are under 6????
Thanks
insiderbuyingselling
Posted - 1 month ago
$APRE new insider buying: 6860 shares. http://insiderbuyingselling.com/?t=APRE
CEOBuysDisclosures
Posted - 1 month ago
$APRE CEO purchased 2,000 shares at $7.29 for a total of $14,580. Gilad Oren now owns 324,770 shares. https://ceo-buys.com
dcast
Posted - 1 month ago
$APRE what is going on here? pops up to $12 after solid uptrend and now back to the $5s?
ryszardm15
Posted - 1 month ago
$APRE Great news and low float. Just bought more shares.